AKRO vs FELE

Comparison between Akero Therapeutics Inc (AKRO, Company) and Franklin Electric Co. Inc (FELE, Company).

AKRO is from the Healthcare sector, while FELE is from the Industrials sector.

5-Year PerformanceAKRO has outperformed FELE, delivering a return of +13.4% compared to +6.1%

AKRO vs FELE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	AKRO(COMPANY)	FELE(COMPANY)
Market Cap	$4.38B	$4.40B
Max Drawdown	79.99%	72.07%
Sharpe Ratio	0.91	0.68
5Y Beta	N/A	0.87
Industry	Biotechnology	Specialty Industrial Machinery
P/E Ratio	-8.72	29.36
Forward P/E	N/A	22.52
PEG Ratio	-0.50	1.86
Dividend Yield	N/A	1.05%
5Y Dividends CAGR	N/A	15.47%
5Y EPS CAGR	23.96%	5.93%
Debt to Equity	0.00%	6.70%
Free Cash Flow Yield	-5.71%	3.85%
P/S Ratio	N/A	2.08
P/B Ratio	N/A	3.38

Market Cap

AKRO

$4.38B

Winner

FELE

$4.40B

Max Drawdown

AKRO

79.99%

Winner

FELE

72.07%

Sharpe Ratio

Winner

AKRO

0.91

FELE

0.68

5Y Beta

AKRO

N/A

FELE

0.87

Industry

AKRO

Biotechnology

FELE

Specialty Industrial Machinery

P/E Ratio

Winner

AKRO

-8.72

FELE

29.36

Forward P/E

AKRO

N/A

FELE

22.52

PEG Ratio

Winner

AKRO

-0.50

FELE

1.86

Dividend Yield

AKRO

N/A

FELE

1.05%

5Y Dividends CAGR

AKRO

N/A

FELE

15.47%

5Y EPS CAGR

Winner

AKRO

23.96%

FELE

5.93%

Debt to Equity

Winner

AKRO

0.00%

FELE

6.70%

Free Cash Flow Yield

AKRO

-5.71%

Winner

FELE

3.85%

P/S Ratio

AKRO

N/A

FELE

2.08

P/B Ratio

AKRO

N/A

FELE

3.38

AKRO vs FELE - Historical Returns

Returns include dividend reinvestment.

Period	AKRO	FELE
1 month	+0.94%	+5.86%
3 months	+22.48%	+13.81%
6 months	-0.11%	+8.41%
1 year	+75.61%	+21.31%
5 years(CAGR)	+13.43%	+6.13%
10 years(CAGR)	N/A	+13.71%
Max(CAGR)	+18.40%	+10.73%

AKRO

+0.94%

Winner

FELE

+5.86%

Winner

AKRO

+22.48%

FELE

+13.81%

AKRO

-0.11%

Winner

FELE

+8.41%

Winner

AKRO

+75.61%

FELE

+21.31%

5Y(CAGR)

Winner

AKRO

+13.43%

FELE

+6.13%

10Y(CAGR)

AKRO

N/A

FELE

+13.71%

Max(CAGR)

Winner

AKRO

+18.40%

FELE

+10.73%

AKRO vs FELE - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	AKRO	FELE
2026	N/A	+7.35%
2025	+94.62%	+0.76%
2024	+18.48%	+3.58%
2023	-52.82%	+22.29%
2022	+152.53%	-13.67%
2021	-14.79%	+39.66%
2020	+28.49%	+19.80%
2019	+21.15%	+34.26%
2018	N/A	-3.82%
2017	N/A	+16.96%
2016	N/A	+48.54%
2015	N/A	-26.74%
2014	N/A	-14.01%
2013	N/A	+40.68%
2012	N/A	+37.68%
2011	N/A	+12.01%
2010	N/A	+33.76%
2009	N/A	+2.65%
2008	N/A	-23.19%
2007	N/A	-23.31%
2006	N/A	+26.04%
2005	N/A	-6.50%
2004	N/A	+41.58%
2003	N/A	+25.22%
2002	N/A	+15.51%
2001	N/A	+28.32%
2000	N/A	-3.30%
1999	N/A	-4.71%

AKRO vs FELE Drawdown Comparison

The maximum drawdown for AKRO was -79.99%, occurring on Oct 27, 2023. Recovery took 413 trading sessions.

The maximum drawdown for FELE was -71.12%, occurring on Mar 5, 2009. Recovery took 1572 trading sessions.

The current AKRO drawdown is -5.06%. The current FELE drawdown is -5.47%.

Rank	AKRO	FELE
#1	-79.99% Jun 13, 2023 - Feb 5, 2025	-71.12% Apr 20, 2006 - Jul 17, 2012
#2	-79.96% Jul 9, 2020 - Oct 13, 2022	-46.45% Dec 26, 2013 - Dec 7, 2016
#3	-57.16% Aug 28, 2019 - Jul 1, 2020	-32.27% May 20, 2002 - Jun 11, 2003
#4	-40.86% Feb 5, 2025 - Apr 8, 2025	-32.02% Feb 5, 2020 - Aug 11, 2020
#5	-32.68% Dec 30, 2022 - Jun 12, 2023	-29.22% Nov 23, 2021 - Aug 12, 2022
#6	-17.41% Dec 16, 2022 - Dec 22, 2022	-23.52% Nov 25, 2024 - Feb 11, 2026
#7	-14.83% Jun 26, 2019 - Jul 12, 2019	-22.39% Sep 18, 2018 - Feb 15, 2019
#8	-13.27% Oct 24, 2022 - Nov 15, 2022	-21.28% Nov 1, 1999 - Mar 1, 2001
#9	-10.67% Nov 30, 2022 - Dec 16, 2022	-20.95% Jul 18, 2023 - Mar 27, 2024
#10	-9.04% Jul 26, 2019 - Aug 7, 2019	-20.66% Feb 3, 2005 - Jul 25, 2005
#11	-8.22% Jun 21, 2019 - Jun 26, 2019	-20.30% Feb 21, 2019 - Oct 29, 2019
#12	-7.35% Aug 7, 2019 - Aug 21, 2019	-18.18% Aug 12, 2022 - Feb 14, 2023
#13	-4.22% Jul 17, 2019 - Jul 22, 2019	-18.18% Feb 12, 2026 - Mar 20, 2026
#14	-4.18% Oct 13, 2022 - Oct 18, 2022	-18.10% Apr 26, 2017 - Sep 27, 2017
#15	-4.09% Nov 16, 2022 - Nov 25, 2022	-16.68% Nov 28, 2017 - May 21, 2018